Albumin as a prognostic marker for ulcerative colitis

doi:10.3748/wjg.v23.i45.8008

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 23, Issue 45

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7404)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-1) series.

Item

Count

PDF

434

WORD

282

HTML

3943

Figures (1-2)

186

Tables (1-1)

160

Sum=5005

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

959

Download

1440

Sum=2399

Dec 7, 2017 (publication date) through Jul 26, 2024

Times Cited of This Article

Times Cited (51)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Gastroenterol. Dec 7, 2017; 23(45): 8008-8016
Published online Dec 7, 2017. doi: 10.3748/wjg.v23.i45.8008

Full Size Figure Download Figure

Figure 2 Cumulative hazard functions for immunomodulator/anti-TNF (A), 2 or more courses of steroids (B), and ulcerative colitis-related colectomy (C).

Citation: Khan N, Patel D, Shah Y, Trivedi C, Yang YX. Albumin as a prognostic marker for ulcerative colitis. World J Gastroenterol 2017; 23(45): 8008-8016
URL: https://www.wjgnet.com/1007-9327/full/v23/i45/8008.htm
DOI: https://dx.doi.org/10.3748/wjg.v23.i45.8008